BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 22004038)

  • 1. Vibrio cholerae infection, novel drug targets and phage therapy.
    Fazil MH; Singh DV
    Future Microbiol; 2011 Oct; 6(10):1199-208. PubMed ID: 22004038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Toxigenic Vibrio cholerae: identification of the ctxB gene].
    Vergara M; Maestre J; Suárez O; Monté R
    Enferm Infecc Microbiol Clin; 1997 Apr; 15(4):181-5. PubMed ID: 9312275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxigenic Vibrio cholerae from environmental sources associated with the cholera outbreak after 'AILA' cyclone in West Bengal, India.
    Palit A; Batabyal P
    Lett Appl Microbiol; 2010 Aug; 51(2):241-3. PubMed ID: 20536711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A bacteriophage encoding a pathogenicity island, a type-IV pilus and a phage receptor in cholera bacteria.
    Karaolis DK; Somara S; Maneval DR; Johnson JA; Kaper JB
    Nature; 1999 May; 399(6734):375-9. PubMed ID: 10360577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic determinants of virulence, antibiogram and altered biotype among the Vibrio cholerae O1 isolates from different cholera outbreaks in India.
    Goel AK; Jiang SC
    Infect Genet Evol; 2010 Aug; 10(6):815-9. PubMed ID: 19580888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of Vibrio cholerae virulence genes in response to environmental signals.
    Peterson KM
    Curr Issues Intest Microbiol; 2002 Sep; 3(2):29-38. PubMed ID: 12400636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Alteration of cholera toxin biosynthesis in Vibrio cholerae 01 as a result of temperate phage 139 integration into bacterial chromosome].
    Eroshenko GA; Smirnova NI
    Mol Gen Mikrobiol Virusol; 2002; (2):9-14. PubMed ID: 12180025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic and phenotypic diversity of quorum-sensing systems in clinical and environmental isolates of Vibrio cholerae.
    Joelsson A; Liu Z; Zhu J
    Infect Immun; 2006 Feb; 74(2):1141-7. PubMed ID: 16428762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of moderate bacteriophage 139 in change in production of cholera toxin in a classic strain of Vibrio cholerae].
    Eroshenko GA; Smirnova NI
    Genetika; 2004 Apr; 40(4):445-53. PubMed ID: 15174276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity in the organization of the CTX genetic element in strains of Vibrio cholerae O139 Bengal isolated from Calcutta, India and Dhaka, Bangladesh and its possible link to the dissimilar incidence of O139 cholera in the two locales.
    Basu A; Mukhopadhyay AK; Sharma C; Jyot J; Gupta N; Ghosh A; Bhattacharya SK; Takeda Y; Faruque AS; Albert MJ; Balakrish Nair G
    Microb Pathog; 1998 Mar; 24(3):175-83. PubMed ID: 9514639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysogenic conversion by a filamentous phage encoding cholera toxin.
    Waldor MK; Mekalanos JJ
    Science; 1996 Jun; 272(5270):1910-4. PubMed ID: 8658163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diversity of Vibrio cholerae strains isolated in Delhi, India, during 1992-2000.
    Das S; Gupta S
    J Health Popul Nutr; 2005 Mar; 23(1):44-51. PubMed ID: 15884751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multidrug resistant Vibrio cholerae O1 El Tor carrying classical ctxB allele involved in a cholera outbreak in South Western India.
    Jain M; Goel AK; Bhattacharya P; Ghatole M; Kamboj DV
    Acta Trop; 2011 Feb; 117(2):152-6. PubMed ID: 21147057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changing genotypes of cholera toxin (CT) of Vibrio cholerae O139 in Bangladesh and description of three new CT genotypes.
    Bhuiyan NA; Nusrin S; Alam M; Morita M; Watanabe H; Ramamurthy T; Cravioto A; Nair GB
    FEMS Immunol Med Microbiol; 2009 Nov; 57(2):136-41. PubMed ID: 19732141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CTX phage of Vibrio cholerae: Genomics and applications.
    Pant A; Das B; Bhadra RK
    Vaccine; 2020 Feb; 38 Suppl 1():A7-A12. PubMed ID: 31272871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dominant
    Hays SG; Seed KD
    Elife; 2020 Apr; 9():. PubMed ID: 32329714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Genetic control of Vibrio cholerae pathogenicity: the temperate filamentous phage CTX, coding for cholera toxin and the "island of pathogenicity"].
    Smirnova NI
    Mol Gen Mikrobiol Virusol; 1999; (4):3-11. PubMed ID: 10621931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholera: pathophysiology and emerging therapeutic targets.
    Muanprasat C; Chatsudthipong V
    Future Med Chem; 2013 May; 5(7):781-98. PubMed ID: 23651092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ability of two different Vibrio spp. bacteriophages to infect Vibrio harveyi, Vibrio cholerae and Vibrio mimicus.
    Payne M; Oakey J; Owens L
    J Appl Microbiol; 2004; 97(4):663-72. PubMed ID: 15357715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phage-bacterial interactions in the evolution of toxigenic Vibrio cholerae.
    Faruque SM; Mekalanos JJ
    Virulence; 2012 Nov; 3(7):556-65. PubMed ID: 23076327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.